You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Photocleavable Bead Technology for Glycomics

    SBC: AMBERGEN, INC            Topic: NIGMS

    DESCRIPTION: Post-translational modifications of proteins (PTMs) play a central role in diverse cellular processes including protein folding, targeting, signal transduction, immune response, adherence, motility and protein degradation. Over 300 differenttypes of PTMs are already known and are found in an estimated 80% of all proteins, accounting in part for the vastly larger proteome compared to ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  2. PEPTIDE BEAD MICROARRAYS MEASURED BY MASS SPECTROMETRY IMAGING

    SBC: ADEPTRIX CORP            Topic: NIGMS

    DESCRIPTION (provided by applicant): New proteomic technologies are urgently needed that can meet the demand of emerging large-scale biological studies. We have developed a novel microarray analysis platform, which enables screening of large bead librariesusing MALDI TOF mass spectrometry imaging. While biological tissue imaging by mass spectrometry is now a well-established technique, MALDI TOF M ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  3. AAV-based toolkit for targeting specific cell types

    SBC: NEUROTARGETING SYSTEMS            Topic: NINDS

    DESCRIPTION (provided by applicant): Our goal is to develop an efficient and inexpensive toolkit for ablating or reversibly inactivating specific cell types in the brain or other organs of mammals. We propose new techniques in which the genes for nitroreductase (NTR) or Drosophila allatostatin receptor (AlstR) are delivered into cells using an adeno-associated viral vector (AAV). Both are fusion ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  4. Non-Invasive System for Identifying Motoneuron Behavior

    SBC: ALTEC, INC            Topic: NINDS

    DESCRIPTION (provided by applicant): This Phase I SBIR describes the first step towards the commercial development of an innovative technology for recording and decomposing the surface electromyographic (sEMG) signal into its constituent motor unit actionpotentials (motoneuron firings). The proposed SBIR will provide a much needed mechanism to further develop, harden, and make more user-friendly ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  5. Low-cost, rapid quantitative Isothermal Assay for HIV RNA using ZNA

    SBC: BIOHELIX CORPORATION            Topic: NIAID

    DESCRIPTION (provided by applicant): In this Phase I project, we propose to investigate a novel primer chemistry and probe detection system called the Zip nucleic acids (ZNA ). ZNAs are oligonucleotides conjugated to a number of cationic spermine moietiesthat enhance the effective concentration of primers and probes near nucleic acid targets. This property has been reported to enhance the speed ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  6. Validation of a new VL vaccine candidate in dogs that significantly protects mice

    SBC: DETECTOGEN INC.            Topic: NIAID

    DESCRIPTION (provided by applicant): The long-term goal of this research program is to validate in dogs a candidate vaccine against visceral leishmaniasis (VL) for evaluation in future clinical evaluations. We have recently described a powerful and reliable antigen discovery strategy to directly identify microbial vaccine candidate antigens in human bodily secretions. We combined RP-HPLC and mass ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  7. A Mucosal RSV Vaccine

    SBC: Biomedical Research Models, Inc.            Topic: NIAID

    DESCRIPTION (provided by applicant): Human respiratory syncytial virus (RSV) is a highly infectious member of the paramyxovirus family causing upper and lower respiratory tract infections. RSV infection is the leading cause of pulmonary disease of the lower respiratory tract (bronchiolitis, pneumonia and respiratory failure) in infants due to virus-induced airway damage and complex inflammatory pr ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  8. UV-Based Approach for Accessing New Antibiotics

    SBC: NOVOBIOTIC PHARMACEUTICALS, LLC            Topic: NIAID

    DESCRIPTION (provided by applicant): The goal of this project is to discover novel antibiotics by activating the silent biosynthetic operons of Actinobacteria. Whole genome sequencing of many Actinobacteria showed that there are 10-20 times more operons coding for secondary metabolites than known compounds in a given species. This opens an attractive opportunity to access a large untapped source o ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  9. Molecular Detection of Invasive Fungal Infections

    SBC: IMMUNETICS, INC.            Topic: NIAID

    DESCRIPTION (provided by applicant): The incidence of fungal infections and, in particular, Candida infections, the fourth most common nosocomial pathogen, has continued to increase over the past 20 years. This increase is due to the increasing numbers ofpatients subjected to severe immunosuppression as a result of transplant procedures, chemotherapy regimens, advances in medical and surgical ther ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  10. Rapid Test for Recent HIV Infection and Incidence Panels for Assay Evaluation

    SBC: LGC CLINICAL DIAGNOSTICS INC            Topic: NIAID

    DESCRIPTION (provided by applicant): Rapid Test for Recent HIV Infection and Incidence Panels for Assay Evaluation Project Summary Accurate estimates of HIV incidence are required for monitoring the epidemic, for targeting resources, and for evaluating the effectiveness of various interventions. Yet the assays that underlie these estimates are widely understood to be flawed. Among the flaws are ( ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government